The Global DNA Sequencing Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research & development activities, supply chain analysis, competitive landscape, and market composition analysis.
The global DNA sequencing market was worth US$ 5.2 Billion in 2019 and is expected to reach US$ 15.3 billion by 2030 at a CAGR of 10.4%. DNA Sequencing is the process in which the sequence of nucleotides in a DNA is determined. It also refers to the process of determining the order of four chemical building blocks called “Bases” (Adenine, Guanine, Cytosine, and Thymine) which play an important role in forming DNA structure. DNA Sequencing can be carried out using several different methods. DNA Sequencing is carried out in two ways mainly - Sanger Sequencing and Next Generation Sequencing. The main difference between these two methods is that Sanger method only sequences a single DNA fragment at a time whereas Next Generation Sequencing method sequences millions of DNA fragments simultaneously. DNA Sequencing has revealed thousands of nucleotide variations linked with specific genetic diseases which helps in understanding the specifics of diseases and their treatment in advance. DNA Sequencing also plays an important role in pharmacogenomics. Pharmacogenomics is a field which studies how genes affect a person’s ability to respond to drugs. Study of pharmacogenomics is necessary to determine which drug will provide the best outcome in patient. Apart from its uses in medical field, DNA sequencing also plays major role in forensic science and in determining ancestry as well.